A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400151 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Ameni Hadj Mohamed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Génomique, Bioinformatique et Chimie Moléculaire (GBCM, EA 7528) Conservatoire national des arts et métiers, HESAM Université, 2 rue Cont…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents, Cell Proliferation, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMPUS France, Tunisian Ministry of Higher Education and Scientific Research.
Abstract (Originalsprache)
Aiming to create an innovative series of anti‐colorectal cancer agents, we designed in this work hybrid triarylmethane compounds. Three hybrid triarylmethanes and their corresponding N ‐oxide analogues were successfully synthesized using an efficient procedure that involved connecting two triarylmethane molecules, through mono‐, bi‐, and triethylene glycol fragments. In our pursuit to develop more soluble molecules, we synthesized a hybrid triarylmethane featuring a lysine‐based spacer through a convergent strategy involving 7 steps. All hybrid compounds were assessed for their antiproliferative activity on human HT‐29 and HCT116 colorectal cancer (CRC) cell lines. Three pyridine N ‐oxide analogs demonstrated notable antiproliferative potential among the set of tested compounds, with IC 50 values ranging from 18 to 24 μM on both human CRC cell lines analyzed. A cytotoxicity study conducted on murine fibroblasts revealed that these three active compounds were not toxic at the IC 50 values, indicating their suitability for further drug development. A docking study was conducted on two representative compounds, one for each series and protein kinase B (AKT) was identified as a potential target of their in anti‐cancer effects. A computational drug‐likeness study predicted favourable oral and intestinal absorption efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire Génomique, Bioinformatique et Chimie Moléculaire (GBCM, EA 7528) Conservatoire national des arts et métiers, HESAM Université, 2 rue Conté, 75003, Paris, France.
- Laboratoire de Chimie hétérocyclique, produits naturels et réactivité (LR11ES39) Université de Monastir Avenue de l'environnement, 5019, Monastir, Tunisie.
- LABCiS, UR 22722, Faculté de Pharmacie, Univ. Limoges, F-87000, Limoges, France.
- Intestinal Regenerative Medicine Laboratory, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, 27607, Raleigh, NC, USA.
- Peptinov, Pépinière Paris Santé Cochin, Hôpital Cochin, 29 rue du Faubourg Saint Jacques, 75014, Paris, France.
Förderung
- CAMPUS France
- Tunisian Ministry of Higher Education and Scientific Research
Zitieren
APA
Hadj Mohamed, A., Ricco, C., Pinon, A., Lagarde, N., Goya-Jorge, E., Mouhsine, H., Msaddek, M., Liagre, B., & Sylla-Iyarreta Veitía, M. (2024). A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes. ChemMedChem. https://doi.org/10.1002/cmdc.202400151
Vancouver
Hadj Mohamed A, Ricco C, Pinon A, Lagarde N, Goya-Jorge E, Mouhsine H, et al. A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes. ChemMedChem. 2024. doi:10.1002/cmdc.202400151
BibTeX
@article{HadjMohamed2024,
author = {Hadj Mohamed, Ameni and Ricco, Christophe and Pinon, Aline and Lagarde, Nathalie and Goya-Jorge, Elizabeth and Mouhsine, Hadley and Msaddek, Moncef and Liagre, Bertrand and Sylla-Iyarreta Veitía, Maité},
title = {A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400151}
}
EUVIMED